Literature DB >> 22469345

Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.

Kurtis B Reed1, Jerry D Brewer, Christine M Lohse, Kariline E Bringe, Crystal N Pruitt, Lawrence E Gibson.   

Abstract

OBJECTIVE: To identify the change in the incidence of cutaneous melanoma over time among young adults. PATIENTS AND METHODS: Using Rochester Epidemiology Project data, we identified patients aged 18 to 39 years who had a first lifetime diagnosis of melanoma from January 1, 1970, through December 31, 2009, in Olmsted County, Minnesota. Demographic and clinical information, including survival, was abstracted, and estimates of the incidence of melanoma and overall and disease-specific survival were generated.
RESULTS: From 1970 to 2009, the incidence of melanoma increased by 8-fold among young women and 4-fold among young men. Overall and disease-specific survival seemed to improve over time; hazard ratios comparing year of diagnosis with mortality were 0.92 and 0.91, respectively.
CONCLUSION: The incidence of cutaneous melanoma among young adults is rapidly increasing, especially among women. Continued close monitoring of this high-risk population is necessary.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22469345      PMCID: PMC3538462          DOI: 10.1016/j.mayocp.2012.01.010

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  21 in total

1.  Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996.

Authors:  J K Robinson; D S Rigel; R A Amonette
Journal:  J Am Acad Dermatol       Date:  1997-08       Impact factor: 11.527

2.  Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures.

Authors:  H K Koh; R W Clapp; J M Barnett; W M Nannery; S R Tahan; A C Geller; J Bhawan; T J Harrist; T Kwan; M Stadecker
Journal:  J Am Acad Dermatol       Date:  1991-04       Impact factor: 11.527

3.  The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

Authors:  L A Ries; P A Wingo; D S Miller; H L Howe; H K Weir; H M Rosenberg; S W Vernon; K Cronin; B K Edwards
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

4.  The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994.

Authors:  L A Merlino; K J Sullivan; D C Whitaker; C F Lynch
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

5.  Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.

Authors:  Leslie J Christenson; Theresa A Borrowman; Celine M Vachon; Megha M Tollefson; Clark C Otley; Amy L Weaver; Randall K Roenigk
Journal:  JAMA       Date:  2005-08-10       Impact factor: 56.272

6.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

Review 7.  Tanning beds, sunlamps, and risk of cutaneous malignant melanoma.

Authors:  Richard P Gallagher; John J Spinelli; Tim K Lee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

8.  Impact of reporting delay and reporting error on cancer incidence rates and trends.

Authors:  Limin X Clegg; Eric J Feuer; Douglas N Midthune; Michael P Fay; Benjamin F Hankey
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

9.  Reporting cutaneous melanoma to cancer registries in the United States.

Authors:  H Irene Hall; Patricia Jamison; John P Fulton; Gayle Clutter; Steven Roffers; Pam Parrish
Journal:  J Am Acad Dermatol       Date:  2003-10       Impact factor: 11.527

10.  Prevalence and characteristics of indoor tanning use among men and women in the United States.

Authors:  Kelvin Choi; DeAnn Lazovich; Brian Southwell; Jean Forster; Sharon J Rolnick; Jody Jackson
Journal:  Arch Dermatol       Date:  2010-12
View more
  66 in total

1.  Opdivo (Nivolumab): Second PD-1 Inhibitor Receives FDA Approval for Unresectable or Metastatic Melanoma.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

2.  Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

3.  Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.

Authors:  Yuan Lu; Mikki Boswell; William Boswell; Susanne Kneitz; Michael Hausmann; Barbara Klotz; Janine Regneri; Markita Savage; Angel Amores; John Postlethwait; Wesley Warren; Manfred Schartl; Ronald Walter
Journal:  Pigment Cell Melanoma Res       Date:  2018-01-29       Impact factor: 4.693

4.  Behaviour of four different B16 murine melanoma cell sublines: C57BL/6J skin.

Authors:  Corina Danciu; Camelia Oprean; Dorina E Coricovac; Cioca Andreea; Anca Cimpean; Heinfried Radeke; Codruta Soica; Cristina Dehelean
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

5.  Attitudes and Behaviors Related to Sun-Safety in College Students.

Authors:  Corey H Basch; Valerie Cadorett; Sarah A MacLean; Grace C Hillyer; William D Kernan
Journal:  J Community Health       Date:  2017-08

6.  Increasing Incidence of Melanoma in the Elderly: An Epidemiological Study in Olmsted County, Minnesota.

Authors:  Jeannette M Olazagasti Lourido; Janice E Ma; Christine M Lohse; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2016-09-28       Impact factor: 7.616

7.  Update on the Epidemiology of Melanoma.

Authors:  Steven T Chen; Alan C Geller; Hensin Tsao
Journal:  Curr Dermatol Rep       Date:  2013-03-01

8.  Incidence of childhood and adolescent melanoma in the United States: 1973-2009.

Authors:  Jeannette R Wong; Jenine K Harris; Carlos Rodriguez-Galindo; Kimberly J Johnson
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

9.  A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma.

Authors:  Azim Hossain; Faisal F Y Radwan; Bently P Doonan; Jason M God; Lixia Zhang; P Darwin Bell; Azizul Haque
Journal:  Apoptosis       Date:  2012-10       Impact factor: 4.677

Review 10.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.